The Vascular Biology and Hypertension Program focuses on molecular and cellular approaches to important problems in cardiovascular medicine. Active in clinical trials include novel therapeutic agents ...
A new report suggests that millions of U.S. adults are unaware they may have undiagnosed cardiovascular risk factors that ...
From the Medical Clinic of the Peter Bent Brigham Hospital. Aided by the Fund for Research in Renal and Vascular Disease. This is the first in a series of papers on the treatment of hypertension with ...
BACKGROUND: Inconsistent selection of reference groups may contribute to inconclusive blood pressure control targets for ...
DelveInsight's Peripheral Vascular Devices Market Insights report provides the current and forecast market analysis, ...
Black or African American individuals demonstrated the highest overall age-adjusted mortality rate for hypertension-related vascular dementia. Deaths associated with hypertension-related vascular ...
Nearly half of all U.S. adults have high blood pressure — a major risk factor for heart attack, stroke, kidney disease and ...
Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the ...
The global peripheral vascular devices market is experiencing steady growth, driven by rising incidences of cardiovascular diseases and an aging population. Advances in minimally invasive technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results